With tariffs threatening pharmaceutical manufacturing, efforts to bring production back home are in progress, though they face several hurdles.
The Trump administration has escalated tariff measures, imposing 25% tariffs on Canada and Mexico and increasing Chinese tariffs by 20%. These tariffs aim to encourage companies to relocate manufacturing back